Artificial intelligence can improve patients' experience in decentralized clinical trials.

Kevin A ThomasŁukasz Kidziński

Published in: Nature medicine (2022)

Keyphrases

artificial intelligence
clinical trial
end stage renal disease
machine learning
big data
ejection fraction
newly diagnosed
deep learning
chronic kidney disease
peritoneal dialysis
prognostic factors
randomized controlled trial
patient reported outcomes
open label
phase ii
study protocol
phase iii